News

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™ (fecal microbiota spores, live-brpk) for Prevention of Recurrence of C. difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDI

Seres Therapeutics 04.26.2023

YourBio Health's TAP® Micro Select Secures FDA 510(k) Medical Device Clearance for Producing Capillary Whole Blood Samples

YourBio Health 04.24.2023

Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That are Programed to Act Only Where Needed

Ampersand Biomedicines 03.07.2023

Flagship Pioneering Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023

03.02.2023

Charles River and Flagship’s Pioneering Medicines Enter Agreement Leveraging AI-Powered Logica with Aim of Creating Novel Therapies for Unmet Medical Needs

Valo 02.16.2023

Flagship Pioneering Announces Appointment of Christian Schade as Growth Partner

01.31.2023

Flagship Pioneering appoints Jonathan Schwartz CEO-Partner and CEO of Invaio

Invaio Sciences 12.15.2022

Flagship Pioneering Unveils Montai Health to Treat and Preempt Chronic Disease Afflicting Two Billion People Worldwide

12.13.2022

Flagship Pioneering Names Ron Hovsepian and Robert Berendes 2022 Pioneering Leaders of the Year

Indigo Agriculture 11.18.2022

Flagship Pioneering Announces Appointment of Pablo J. Cagnoni, M.D., as Executive Partner

11.02.2022

Loading